Back

Ferroptosis contributes to the development of cardiac dysfunction in iron overload cardiomyopathy

31 August 2024 (11:00 - 11:30)
Organised by: Logo
Congress Presentation Part of: Ferroptosis and iron metabolism Cardiomyopathies ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Miss Xihan Fan

Kunming (China)

4 More presentations in this session

Presentation thumbnail
S-nitrosylation of aconitase-2 facilitates coronary microembolization-induced cardiac injury by suppressing iron-sulfur cluster assembly
Doctor Z. Chen (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Vitamin K2 and the Vitamin-K-Cycle-Enzyme VKORC1L1 improve endothelial regeneration by inhibiting endothelial-mesenchymal transition, inflammatory cell activation and ferroptosis
Doctor M. Al Zaidi (Bonn, DE)
Abstract Slides Video
Presentation thumbnail
The contribution of iron metabolism to heart failure: a haematological and biochemical perspective
Doctor A. Melicio (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
The contribution of SLC7A11-mediated ferroptosis to cardiac injury in iron overload cardiomyopathy: an in vitro study
Miss J. Hou (Kunming, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Ferroptosis and iron metabolism

The Event

Event poster

ESC Congress 2024

31 August 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Iron chelation therapy failed to improve cardiac dysfunction caused by mitochondrial injury in rats with iron overload cardiomyopathy a 7T Cardiac MR research in vivo
thumbnail
Congress Presentation
TREM2 mcrophage mitigates atherosclerosis by suppressing FTH1/NCOA4-dependent ferroptosis
thumbnail
Congress Presentation
The contribution of SLC7A11-mediated ferroptosis to cardiac injury in iron overload cardiomyopathy: an in vitro study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources